Hospital
Financials

SickKids is committed to operational efficiency, transparency and accountability. We support evidence-based decisions to enhance our financial health, conduct business under the principle of fiscal prudence and act with integrity and good judgment when allocating resources.

For 2023-2024 the Hospital had an operating deficit of ($1.9M). Included in the deficit was $15.1M in restricted investment income (not available for operations) for the Hospital's debenture retirement funds, its supplemental pension plan and donor restricted funds. After adjusting for this restricted investment income to better understand the true state of the Hospital's operations and funding levels, we note that the Hospital continues to be challenged by a significant structural deficit, as reported in previous years.

The structural deficit relates to many years where the rate of inflation, progressive increases in patient acuity and other cost pressures are outpacing rate of funding growth from our major funder, the Ministry of Health/Ontario Health. The Hospital continues to work with the Ministry of Health and Ontario Health to review funding levels and the funding model for specialized paediatric care.

2023-24 Total Hospital Revenues and Expenses - Hospital Revenues For the year ended March 31, 2024
Sources of RevenueAmount (In millions)Percentage
Amortization $38.1 3%
Commercial Ventures$50.0 million 4%
Patient Care and Other $68.5 5%
SickKids Foundation $127.4 9%
Research Grants $171.2 13%
Investment Income $28.4 2%
Ministry of Health/Ontario Health $866.0 64%
Total$1.35 Billion
2023-2024 Total Hospital Revenues and Expenses - Hospital Revenues For the year ended March 31, 2024
Sources of Souces of ExpensesAmount (In millions)Percentage
Administrative and General $37.4 3%
Depreciation and Accretion$78.3 6%
Other Operating Expenses $152.2 11%
Clinical Supplies and Drugs $205.3 15%
Interest $22.1 2%
Compensation $856.0 63%
Total$1.35 Billion
2023-24 Total Patient Care Revenue and Expenses - Total Patient Care Revenue for the year ended March 31, 2024
Revenues (In Millions)Amount (In millions)Percentage
Fee-for-Service $44.8 5%
Other $58.7 6%
Ministry of Health $808.4 89%
Total$911.9 Million
2023-24 Total Patient Care Revenue and Expenses - Total Patient Care Expenses for the year ended March 31, 2024
Expenses (In Millions)Amount (In millions)Percentage
Administrative and General $21.1 3%
Depreciation and Accretion $46.9 6%
Other Operating $69.1 9%
Supplies and Drugs $82.7 10%
Interest Expense $10.3 1%
Compensation $566.9 71%
Total$944.8 Million
2023-24 Investment Performance - Investment Performance for the year ended March 31, 2024
Hospital Investments (In Millions)Amount (In millions)Percentage
Other $29.9 7%
Patient Support Centre Unused Debenture Proceeds $60.6 15%
Debenture Retirement Sinking Funds $88.7 21%
Post Retirement Benefit Assets $238.8 57%
Total$418.0 Million
2023-24 Investment Income/(Loss) - Restricted Investment and Unrestricted Income/(Loss)* for the year ended March 31, 2024
Restricted Investment Income/(Loss) (In Millions) by Financial YearAmount (In millions)
2019/2020 -$2.5
2020/2021 $15.1
2021/2022 $20.1
2022/2023 $14.3
2023/2024 $15.1
Unrestricted Investment Income/(Loss) (In Millions) by Financial YearAmount (In millions)
2019/2020 $1.0
2020/2021 $0.8
2021/2022 $1.0
2022/2023 $7.7
2023/2024 $13.3
2023-24 Total Research Institute Revenues and Expenses - Sources of Resource Institute Funding for the year ended March 31, 2024
Sources of Research Institute Funding (In Millions)Amount (In millions)Percentage
Industry Partnerships and Commercialization Income $3.7 2%
External Billings (Core Facilities) $6.1 2%
SickKids Foundation $87.2 32%
Research Grants and Awards $174.7 64%
Total$297.8 Million
2023-24 Total Research Institute Revenues and Expenses - Sources of Resource Institute Expenditure for the year ended March 31, 2024
Sources of Research Institute Expenditure (In Millions)Amount (In millions)Percentage
Internal Costs $72.3 26%
External Grant Funded Costs $209.7 74%
Total$305.5 Million
2023-24 Total Research Internal Expenditure - Total Research Internal Expediture for the year ended March 31, 2024
Sources of Total Research Internal Expenditure (In Millions)Amount (In millions)Percentage
Technology and Licensing Expenses $3.8 5%
Depreciation and Accretion $6.0 8%
Scientists Salaries (Net of $15.5M Recovery) $6.6 9%
Debenture Interest $10.4 15%
Research Operations (Net of $4.4M Recovery) $8.0 11%
Core Infrastructure $1.9 3%
Peter Gilgan for Research and Learning $17.4 24%
Start-Up and Scientific Support (Net of $5.2M Recovery) $18.2 25%
Total$77.2 Million

2023-2024 Total Hospital Revenues and Expenses

revenues

(In millions)

$1.35 billion

expenses

(In millions)

$1.35 billion

2023-2024 Total Patient Care Revenue and Expenses

revenues

(In millions)

$911.9 million

Expenses

(In millions)

$944.8 million

2023-2024 Investment Performance

Hospital Investments

(In millions)

$418.0 million

Investment Income/Loss

(In millions)

Restricted Investment Income/Loss*

*Restricted investment income cannot be used for operations.

Unrestricted Investment Income

Restricted Investment Income/Loss*

Unrestricted Investment Income

2023-2024 Total Research Institute Revenue and Expenses

Sources of Research Institute Funding

(In millions)

Industry Partnerships and Commercialization Income $2.8 1%. Research Awards and Contracts $185.8 63%. SickKids Foundation $102.3 34%. External Billings (Core Facilities) $6.9 2%

$297.8 million

Research grants and awards sources over $1 million

(In millions)

$102.3
SickKids Foundation
$53.6
Canadian Institutes of Health Research
$25.5
Canada Foundation for Innovation
$15.3
National Institutes of Health
$7.9
Tri-Agency Institutional Programs
Secretariat – Research Support Fund
$7.8
Ministry of Colleges and Universities
$6.4
Ministry of Health
$6.1
Bill & Melinda Gates Foundation
$5.8
Tri-Agency Institutional Programs
Secretariat – Canada Research Chairs
$3.8
Genome Canada
$2.1
Public Health Agency of Canada
$2.1
Natural Sciences and Engineering Research Council of Canada
$1.9
University of Toronto
$1.4
Canadian Cancer Society Research Institute
$1.2
Cystic Fibrosis Foundation
$1.2
Social Sciences and Humanities Research
$1.2
The W. Garfield Weston Foundation
$1.2
C.H.I.L.D. Foundation
$1.2
Vertex Pharmaceuticals Incorporated
$1.0
Ontario Brain Institute
$1.0
The Leona M. and Harry B. Helmsley Charitable Trust

Total Research Institute Expenditure

(In Millions)

Internal Costs $77.2 million 25%. External Grant Funded Costs $228.3 million. 75%.

$305.5 Million

Total Research Internal Expenditure

(In millions)

$77.2 million